Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02193282
Brief Title: Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

First Submitted : July 15, 2014
First Submitted that Met QC Criteria : July 15, 2014
First Posted : July 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 18, 2021
Last Update Posted : March 19, 2021